ABSTRACT In many eukaryotic cell types, receptor activation leads to the formation of inositol 1,4,5-trisphosphate (IP3) which causes calcium ions (Ca) to be released from internal stores. Ca release was observed in response to the muscarinic agonist carbachol by fura-2 imaging of N1E-115 neuroblastoma cells. Ca release followed receptor activation after a latency of 0.4 to 20 s. Latency was not caused by Ca feedback on IP3 receptors, but rather by IP3 accumulation to a threshold for release. The dependence of latency on carbachol dose was fitted to a model in which IP3 synthesis and degradation compete, resulting in gradual accumulation to a threshold level at which Ca release becomes regenerative. This analysis gave degradation rate constants of IP3 in single cells ranging from 0 to 0.284 s -I (0.058_ 0.067 s -1 SD, 53 cells) and a mean IP3 lifetime of 9.2 +-2.2 s. IPs degradation was also measured directly with biochemical methods. This gave a half life of 9 • 2 s. The rate of IP3 degradation sets the time frame over which IP3 accumulations are integrated as input signals. IP~ levels are also filtered over time, and on average, large-amplitude oscillations in IP3 in these cells cannot occur with period < 10 s.
INTRODUCTION
Inositol 1,4,5-trisphosphate (IP3) plays a central role in mobilizing calcium in eukaryotic cells (Berridge and Irvine, 1989; Rana and Hokin, 1990) . The activation of neurotransmitter or hormone receptors on the cell surface causes G-proteinmediated activation of phosphoinositide-specific phospholipase C (PLC). PLC converts phosphatidyl-l,4-bisphosphate (PIP2) in the plasma membrane to IPs and diacylglycerol (Rhee, Suh, Ryu, and Lee, 1989) and IP3 activates channels in the endoplasmic reticulum to cause the release of stored calcium ions (Ca) into the cytoplasm. IP3-dependent Ca release can occur in a spatially and temporally organized manner, taking the form of oscillations or waves which cross within and between cells (Berridge, 1990; Jaffe, 1991) .
The lifetime of IP3 determines whether regenerative IP3 production could underlie the propagation of a Ca wave. Ca waves cross cells without diminishing or slowing and are, therefore, generated by a process in which a messenger is regeneratively produced (Winfree, 1987) . In one possible mechanism, the diffusion of locally produced IP3 is rate limiting (Allbritton, Meyer, and Stryer, 1992) , and a wave of IP3 accompanies the Ca wave as it crosses the cell. No indicator is available that would allow IP3 to be visualized. However, knowledge of the lifetime of IP3 is useful in calculating whether a concentration gradient of IP5 might exist at the time of wave initiation.
The lifetime and diffusion constant of IP3 in cytoplasm also together determine its spatial range of action. These variables have been measured under certain conditions (Allbritton et al., 1002; Irvine, ~mggfird, Letcher, and Downes, 1085; Stauderman, Harris and Lovenberg, 1088; Breer, Boekhoff, and Tarelius, 1990 ), but little is known about how quickly IP3 is degraded in single cells. The rate of second messenger degradation is of particular interest in spatially extended structures such as dendritic arbors. Computational models of the spread of second messengers from a dendritic spine to neighboring spines predict that biochemical signals are compartmentalized and that the rate of messenger removal is critical in this function (Koch and Zador, 1003) .
In this study, the delay to calcium release was used to infer the lifetime of IP3 in individual cells. This analysis was predicated on the steep dose-response curve of IPs action upon its receptor (Meyer, Holowka, and Stryer, 1088; Parker and Ivorra, 1992) . This was used in a simple model of IPs accumulation and degradation, in which Ca release begins when IP3 levels reach a threshold. The dose dependence of latency could then be used to derive the rate of IP~ degradation in single cells. For comparison, the lifetime of IP3 was determined independently by direct biochemical assay. Results from the two measures agreed with one another.
Our preparation for the study of IP3-mediated Ca release is the mouse neuroblastoma cell line N1E-115, which expresses muscarinic M I acetylcholine receptors Richelson, 1984, 1986; Mathes, Wang, Vargas, and Thompson, 1992) . N1E-115 cells are well suited for the work described here. Like many eukaryotic cells, they have the IP3 production and Ca release machinery (Surichamorn, Forray, and E1-Fakahany, 1990) . The low expression of muscarinic receptors (Fisher and Snider, 1087) allows the kinetics of Ca release to act as a sensitive assay for receptor activation. Finally, these cells do not form cholinergic synapses (Kimura, Oda, Deguchi, and Higashida, 1992) so that evoked responses are the direct result of receptor activation.
MATERIALS AND METHODS

Cell Culture
N 1E-115 neuroblastoma cells were obtained from the UCSF Cell Culture Facility, maintained without antibiotics in Dulbecco's Modified Eagle Medium (Sigma Chemical Co., St. Louis, MO) and 10% fetal bovine serum (Hyclone), and subcultured once a week. For experiments, cells were plated on cover slips and grown to 60-80% confluence; at this time the medium was replaced with differentiation medium containing 2% dimethylsulfoxide (Kimhi, Palfrey, Spector, Barak, and Littauer, 1977) . Cells were used 7-21 d after differentiation.
Calcium Imaging
Cells were loaded with the calcium indicator fura-2 by bathing in a solution containing 5 p,M fura-2/AM (Molecular Probes, Inc., Eugene, OR) and 0.025% pluronic acid F-127 (Molecular Probes, Inc.) for 60 min at 20~ After loading, the cells were rinsed and transferred to an experimental chamber. Loading with other, additional chelators was achieved by incubating cells with AM ester while they were on the microscope stage. The resulting second buffer load was estimated to be 25-100 ~.M by measuring the attenuation of [Ca] i rises in response to high-potassium depolarization (Wang, S. S.-H., and S. H. Thompson, manuscript in preparation). Fluorescence imaging was performed on a Nikon Diaphot epifluorescence microscope equipped with 20x Fluor objective (Nikon), Hamamatsu C2400 silicon-intensified target camera and a Sony VHS video tape recorder. Excitation illumination by a Xenon ardamp was filtered through 10-nm bandpass interference filters centered at 340 and 380 nm (Corion Corp., Holliston, MA), which were mounted on a computer-controlled filter wheel. Calibration of fluorescence to units of calcium was performed off line using a pipeline image processor (MegaVision, Santa Barbara, CA). Background-subtracted and frame-averaged F34o/F38o ratios were calibrated using standard solutions of fura-2 between two cover slips according to the equations of Grynkiewicz, Poenie, and Tsien (1985) . The measured calibration parameters were 
where ~ = Faso.min/Fsso,ma x and is a constant of the imaging system.
[Ca]i at later times could then be calculated from F380 using the Henderson-Hasselbalch equation, as is done for single-wavelength dyes (Kao, Harootunian, and Tsien, 1989) . A similar procedure has been employed by other investigators (Neher and Augustine, 1992 
Drug Applications
Carbachol solutions were applied by total, vigorous replacement of the chamber saline using a computer-controlled perfusion device. Six successive exchanges with normal saline at the end of the drug application ensured that no drug remained in the chamber. The external saline contained (in millimolar): NaCI, 137; KCI, 5.4; CaCI2, 1.8; MgSO4, 0.8; KH2PO 4, 0.4; Na2HPO4, 0.3; glucose, 23; and NaHEPES, 20 (pH 7.4 , T = 27-30~ A 15--30 min recovery period between agonist applications ensured the reproducibility of the response.
IP3 Determinations
IPs determinations were done by competitive radioligand binding displacement of [SH]-IPs from a binding protein obtained from bovine adrenal granules (Palmer, Hughes, Lee, and Wakelam, 1989; No. TRK, 1000, Amersham Life Sciences, Arlington Heights, IL) . On the day of the experiment, the medium was decanted, the cells were washed with 2 • 2 ml normal external saline (pH 7.4 at 30~ and vehicle or 1 mM carbachol was added for 30 s. The reaction was either stopped immediately or continued in the presence of 10 I~M atropine for 10-30 s. At the end of the drug exposure, the cover slip was transferred to another petri dish and the reaction was stopped with ice-cold 20% perchloric acid. The acid cell lysate was transferred to a microfuge tube and the precipitated protein was separated by centrifugation. The assays were done as specified in the kit. The pH of the PCA lysate was adjusted to 7.5 using 10 ~! 1 N KOH in the presence of 2 ~! Universal Indicator (Eastman Kodak Co., Rochester, NY) and the precipitated potassium perchlorate was removed by centrifugation. 100 o.l of the supernatant was used to displace binding in ice-cold microfuge tubes containing 100 p,1 buffer (0.1 M Tris, 4 mM EDTA, 4 mg/ml BSA, pH 9.0); 100 I~l (~2.5 kilobecquerels activity) (D-myo-[3H]-IP3); and 100 p.1 IPs-specific binding protein. After vortex mixing and incubation on ice for 15 rain, the tubes were centrifuged and the bottom part of the tube containing the protein was cut with a razor and transferred to a vial for scintillation counting. A standard curve for IPs ranging from 0.19 to 25 pmol IP~ was prepared simultaneously in the same way as the unknown. 
Latency and Rise Time Analysis
Rises in [Ca] i in response to carbachol application were preceded by a period during which little or no change in [Ca]i could be seen (Fig. 1 A) . This period, latency, was defined as the time between initial presentation of agonist and the time of fluorescence change 20% of the way to peak [Ca] i. Rise time was defined as the time from 20% to 80% fluorescence change. These times were calculated by fitting traces of Fss0 fluorescence sampled 3-30 times/s. Baseline F0 and peak AF were calculated from the trace. The time at which the fluorescence trace crossed the criterion point (20% or 80% change from baseline toward peak) was calculated by fitting the data for 2--4 samples on either side of the crossing point to a linear function. Uncertainty in the crossing time was calculated from the estimated error of the fit (Bevington, 1969) . Fits were accepted if (a) peak AF/Fo > 0.1. (b) The peak AF was attained more than four samples before the end of the recording period (usually 30 s). (c) Uncertainty in the time was less than two sample intervals. All data were corrected to take into account the dead time of the drug application system, ~ 0.5 s. Dead time was measured by exchanging a clear solution for one containing methylene blue, and vice versa.
RESULTS
The muscarinic agonist carbachol mobilizes calcium in differentiated N1E-115 neuroblastoma cells. Responses from a cell exposed to 1 mM carbachol are shown in Fig. 1 A. The initial phase of Ca release is characterized by a period during which little or no change in [Ca] i is observed. We defined latency as the length of the interval from the beginning of agonist exposure to the time at which F380 fura-2 fluorescence had decreased 20% of the way to its first minimum. Latency varied between 0.4 and 20 s (average for 1 mM carbachol 5.8 ---3.9 (SD) s, 130 cells in four experiments). After allowing a recovery period of at least 15 min for the Ca stores to be restored to their initial state, subsequent applications of the same concentration of carbachol resulted in approximately equal latencies (Fig. 1 B ; r = 0.87, n = 59 cells).
The latency to a given dose of carbachol was unchanged even after up to five 30-s agonist challenges. Another reproducible quantity was rise time, defined as the time needed for F~80 to change from 20 to 80% of its total peak value (average rise time 2.8 -2.1 s, r = 0.87, 53 cells). Some cells showed oscillations in Ca for as long as agonist was present; these too were reproducible. In some cases, the peak [Ca]i decreased with successive applications of carbachol, possibly reflecting the filling state of the stores or a redistribution of dye.
Could latency result from the buildup of IP~? If this were so, then pretreatment with a low dose of agonist would shorten the latency to a second, higher dose of agonist by stimulating the formation of a subthreshold amount of IP3. Fig. 2 A shows two recordings from a cell exposed to 1 mM carbachol. For the second (dashed) trace the application of 1 mM carbachol was preceded by a prepulse of 100 pLM carbachol lasting 10 s. This shortened the latency from 6.6 to 3.6 s. During the prepulse little change in [Ca] i was visible. In trials where the prepulse was 15 s or less, latency was shortened in all 11 cells tested (Fig. 2 B) . The effect was smallest in cells with short latencies, and in these cases the prepulse itself always caused Ca release. The decrease in latency was proportional to the length of the prepulse for prepulses up to 15 s long (Fig. 2 B) . However, a prepulse of 10 ~M carbachol lasting 45 s had very little effect on latency (filled symbol), much smaller than expected for this agonist exposure expressed in units of (dose x duration) ( Fig. 2 B, fitted line) . This indicates that the messenger generated during the long prepulse had decayed during that time.
Determining Single-CeU IP3 Lifetime from Response Latency
For experiments in which response desensitization was negligible, it was possible to measure latencies to a range of concentrations of carbachol in the same cell. Fig. 3 A shows Ca responses to 30, 100, and 300 o~M, and 1 mM carbachol. Ca release is slower at lower doses of agonist and the latency is longer. We analyzed the dependence of latency on agonist dose using a model in which IPs accumulates to a threshold to cause Ca release and is degraded with lifetime x. This model is consistent with the prior observation that gradual photolysis of IP3 leads to delayed, sharp rises in Ca (Parker and Ivorra, 1992) . In this model, higher concentrations of agonist cause greater activation of phospholipase C and faster generation of IP3. Therefore, it predicts that latency will decrease with increasing muscarinic receptor occupancy. Furthermore, the relationship between inverse muscarinic receptor occupancy and latency will be an exponential with time constant "r (see Appendix A). A fit to this model for two cells (Fig. 3 B) gives IP3 lifetimes of 5.7 -+ 0.5 and 13.4 -+ 0.8 s.
In this study the rate constant for IP3 degradation, k = 1/~, varied widely over the population of cells and was approximately exponentially distributed ( histogram of values of k to an exponential gave a mean k of (k) = 0.11 +_ 0.03 s-1, corresponding to a lifetime of l/(k) = 9.2 -+ 2.2 s. The arithmetic mean value ofk was 0.058 --. 0.067 s -L (SD, 53 cells in three experiments), and the uncertainty in k was 0.023 +-. 0.027 s -l (SD). In 28% of cells, the latency and inverse muscarinic receptor occupancy were approximately linearly related. Assuming that the longest lifetime detectable by fitting to an exponential is twice the longest latency observed, this corresponds to -r > 40 s.
Measuring IP3 Lifetime Biochemically
For a heterogeneous population of cells with exponentially distributed k, the overall half life of IPs is predicted to be the inverse of the mean of the distribution, 1/(k) (see Appendix A). We measured the time course of IP3 degradation in cell populations by FIGURE 4. Direct biochemical determination of IP3 content of cells before and after exposure to carbachoi. Cells were exposed to 1 mM carbachol for 30 s. The cells were iysed at the end of the carbachol exposure or after replacing carbachol with 10 ~M atropine for 10, 20, or 30 s. IP3 levels were assayed by competitive binding assay as described in Materials and Methods. The IP3 concentrations in each of four experiments were normalized to basal levels of IP3. Interpolation to the data give a half life for IP3 of 9 ---2 s. The curve is a plot of the expected time course of IP3 based on the latency analysis (see Appendix A), with a half life of 9.2 s.
direct biochemical determination of IPs content before and after exposure to carbachol. The basal level of IP~ was 10 -+ 3 nM (n = 4). Cells were stimulated with 1 mM carbachol for 30 s, and after carbachol stimulation, IP3 content increased 3.5 -+ 0.7-fbld over basal levels to an estimated 35 -+ 10 nM. In parallel experiments, carbachol stimulation was followed by incubation with 10 ~M atropine for 10-30 s to block further IP3 production, and IP3 was determined at the end of the atropine incubation (Fig. 4) . These data show that IP3 is degraded with a half life of 9 +-2 s, eventually returning to basal levels.
Tests of Calcium Feedback Mechanisms: Inhibiting Ca Feedback
Calcium itself might contribute to setting the latency. In this alternative hypothesis, latency is caused by the gradual accumulation of small amounts of Ca that feed back positively to cause regenerative calcium-induced calcium release (Dupont, Berridge, and Goldbeter, 1990) . Ca could also serve to shorten latency by enhancing IP3 action to cause more Ca release, analogous to the role of depolarization in the initiation of an action potential. If either of these were so, then our latency analysis would not give accurate IP~ lifetime information. It was therefore important to test for the presence of Ca feedback. If Ca were playing a positive feedback role in determining the kinetics of release, then it should be possible to decrease the feedback by loading cells with Ca buffers.
This treatment would attenuate the rise in free [Ca] i caused by a small amount of Ca release and therefore prolong latency or rise time.
Ca responses were recorded before and after additional loading with membranepermeant acetoxymethyl esters of Ca buffers. The addition of BAFTA-series Ca buffers (2-5 I*M of AM ester for 30 min) decreased the peak [Ca]i and slowed release (Fig. 5 A) . This buffer loading caused the rise time to increase from 2.1 -+ 0.4 to 4.6 _+ 0.5 s (mean -+ SEM, 37 cells in 10 experiments; Fig. 5 B) . The latency also increased somewhat, from 4.5 _+ 0.3 s to 6.3 + 0.5 s (Fig. 5 C) . Loading with the nonbuffering compound AM-APDA ("half-BAPTA/AM") (10 IxM, 30-50 min) had no effect on latency or rise time, showing that the AM-loading procedure itself had no deleterious effect on the Ca release machinery. The large increase in rise time suggests that Ca exerts significant positive feedback upon Ca release machinery during the rising phase of Ca release. However, it participates to a lesser extent in regulating latency.
If direct calcium-induced calcium release (CICR) contributes to the N1E-115 calcium release signal, then drugs which modulate direct CICR should interfere with calcium release. We applied drugs known to act upon the ryanodine receptor, which is thought to mediate direct CICR (Ashcroft, 1991) . The response to 1 mM carbachol was measured first in control conditions, and drugs were applied 8-20 min after carbachol washout. The magnitude of Ca release was then measured during a second application of carbachol 5-10 min later. Ca release was unaffected by the blockers dantrolene (30-100 IxM; 111.8 -+ 10.4% of control, 29 cells in two experiments) and ryanodine (1 IxM; 85.4 -15.4% of control, 36 cells in two experiments), or by the channel agonist caffeine (10 mM; 104.5 + 4.5% of control, 14 cells in one experiment). Ryanodine treatment also had no effect on latency (2.67 + 0.23 s before, 2.81 + 0.24 s after; average change 0.14 + 0.10 s SEM). The latency to Ca release was also unaffected by acute removal of external Ca (Wang and Thompson, 1994) .
Response Scaling at Low Agonist Doses
In search of further evidence for the influence of feedback mechanisms on rise time, we compared the dependence of rise time and latency on carbachol dose. Rise times and latencies for the cell of Fig. 3 A decreased with higher agonist dose. If the latent and rising phases of release had equal feedback, then they would remain proportional to one another at all agonist doses and it should be possible to match the time courses by scaling the time axis. A transformation of the Ca release kinetics for 300 txM, 100 and 30 p.M carbachol is shown in Fig. 6A . In this example, the scaled time single-cell data set as the ratio of rise time to latency, which was 0.44 -+ 0.17 (SD) at 100 p~M carbachol and 0.30 -+ 0.16 at 1 mM carbachol and was higher for the lower agonist dose in 10 of 11 cells (Fig. 6 B) . This relative shortening of rise time at high agonist doses is consistent with the presence of regenerative Ca feedback in the rising phase of release. However, scaling is exact only if the IP3 time course is linear, and the presence of IP3 degradation predicts that there will be curvature in the IP3 time course. This curvature is magnified if the action of IPs on its receptor is positively cooperative (Fig. 9, A and B) . Since this curvature does not scale (Fig. 6 C) , it might also be sufficient to explain the lack of scaling of Ca release.
Increasing Feedback by Blocking Ca Pumping Activity
As a means of increasing the amount of feedback caused by calcium, cyclopiazonic acid (CPA) was used to block reuptake of Ca into the ER (Mason, Garcia-Rodriguez, and Grinstein, 1991 [Ca] i stems at first from leak from the ER, and later from influx through a depletion-activated current. Detailed kinetic studies in these cells using the pump blocker thapsigargin show that the contribution of influx to [Ca] i is significant after ~ 30 s (Mathes and Thompson, 1994) . We were interested in the effect of blocking Ca pumping activity acutely, without altering resting [Ca]i or store content. We therefore measured the effect of CPA treatment on latency at times when pumps were blocked, but before cytoplasmic [Ca]i had risen significantly. Also, the stores were still full, because acute treatment with CPA did not significantly alter the magnitude of carbachol-evoked Ca release. Cells were challenged once with 1 mM carbachol, and again in a second trial at the end of (Fig. 7 B) . Overall, the response size was somewhat increased (mean change 4.8 -1.5% ~ss0, 53 -+ 11 nM A[Ca]i). However, CPA treatment did appear to attenuate Ca oscillations (Fig. 7 A) . These observations show that the ability of the ER to mobilize Ca was not compromised by acute CPA treatment, but that Ca oscillations later in the response require ER Ca pump activity.
If the latent period is terminated in part by positive Ca feedback, then blocking ER Ca pumps with CPA might shorten latencies by reducing the rate at which released Ca is cleared from the cytoplasm. We therefore measured the effect of CPA on carbachol-evoked Ca release, and found that neither latency nor rise time was significantly changed by acute CPA treatment (Fig. 7 B) . The average latency was 3.7 + 1.7 s (SD) to the first dose ofcarbachol, and 3.1 _ 1.0 s after CPA exposure (12 cells, three experiments). On average, the change in latency was -0.56 -+ 0.39 s (SEM; not significant by t test, P > 0.1). Rise times were 2.1 + 1.1 s at first, and 1.9 + 1.3 s after CPA treatment (average change, -0.22 + 0.26 s, SEM; not significant, P > 0.4).
DISCUSSION
We have measured the lifetime of IP3 in two ways: physiologically by analysis of latency to Ca release, and by direct biochemical determination. The methods both give an average half life of 9 s, showing that at least one parameter of Ca release in single cells, response latency, can be explained in part by a biochemical parameter, the degradation rate constant of IPs. This rate varied greatly from cell to cell, suggesting that the ability of individual cells to integrate IP3-mediated signals is similarly variable.
Latency Stems from Messenger Accumulation
The latent period that follows agonist application can be accounted for by the accumulation of a messenger to a threshold level necessary for the initiation of Ca release. In individual cells, latency becomes shorter with increasing doses of carbachol, indicating that increased muscarinic receptor occupancy leads to a faster accumulation of messenger. Furthermore, exposure to a brief, subthreshold level of carbachol is able to prime a cell in the absence of a visible change in [Ca] i, so that the latency to a dose of agonist becomes shorter. The primary candidate for this accumulating messenger is IP3.
Contribution of Calcium Feedback to Latency
Calcium-induced calcium release has been proposed as a mechanism for ending latency, either by direct calcium-induced calcium release involving ryanodine receptors (Dupont et al., 1990) or by positive Ca feedback acting upon IP3 receptors (Keizer and De Young, 1992; Dupont and Goldbeter, 1993) . In NIE-115 cells, calcium release is unaffected by ryanodine receptor modulators, indicating that direct CICR does not contribute to agonist-evoked Ca release. Additional loading with fura-2, however, slowed Ca release during the rising phase, suggesting that Ca feedback participates during this part of the response. The effect on latency was smaller, but may also reflect some degree of Ca feedback before IPa levels reach threshold.
Experiments with cyclopiazonic acid, an inhibitor of the ER Ca/ATPase, do not provide evidence that positive Ca feedback plays a role in setting latency. CPA was able to block Ca oscillations, but did not change either latency or rise time. However, because IP3R and Ca/ATPases are separate molecular entities, blocking pumps would not necessarily increase feedback near an IPs receptor, because Ca pumping does not play a significant role in attenuating Ca concentration profiles near channels (Roberts, Jacobs, and Hudspeth, 1991) . Calcium waves, on the other hand, are thought to rely on local amplification by calcium diffusion (Jaffe, 1991) , but blocking or overexpressing Ca pumps in oocytes does not affect the speed of Ca waves (Camacho and Lechleiter, 1993) . That result is consistent with our findings if CPA enhances global Ca accumulations, but the Ca feedback that takes place in a Ca wave occurs between nearby channels.
IP~ Threshold Mechanism for Response Latency
The steep dose dependence of IP3 acting to promote Ca release suggests either cooperativity of IP3 action at its receptor, or local feedback by Ca between IP3 receptors. When combined with the assumption of gradual IP3 accumulation to threshold, this phenomenon provides an explanation for the quiescent period preceding Ca release. One specific mechanism could be that positive cooperativity of IP~ action on its receptor causes the rate of Ca release to increase sigmoidally with a linear increase in IP3 concentration. In this case, the IP3 threshold is operationally defined as the point of steepest slope on the dose:response curve of IP3 action upon its receptor; this occurs when [IPs] = KD (Fig. 9 B) .
Alternately, the key step in generating an IP~ threshold may be local feedback by Ca from one IPa receptor to increase the open probability of other IPs receptors. Ca feedback on IPa receptors has been observed at micromolar levels of Ca (Iino, 1990; Bezprozvanny, Watras, and Ehrlich, 1991; Finch, Turner, and Goldin, 1991) . During the latent period this would only be achieved in the domain immediately surrounding an open IP3 receptor channel. At low levels of IP3 (Fig. 8, top) , IP~-bound receptors would be farther apart than the size of a domain, and so Ca release from one channel would not be able to reach other channels to cause further channel opening. As IP3 levels rise, the average distance between bound receptors decreases, and when bound IP~ receptors are closer to one another than the size of a domain, Ca from one open channel can cause further release from nearby channels (Fig. 8, bottom) . Threshold for this regenerative effect is reached when the distance between IPs-bound receptors is smaller than the size of a single-channel Ca domain. The IP3 threshold is then set by a number of parameters, including the affinity of the receptor for IPs, its sensitivity to Ca, the mean distance between receptors, and the size of a Ca domain.
Analyzing Latency for IP~ Lifetime
Either of these two mechanisms leads to a sharp rise in Ca as IP3 rises past a threshold level. A threshold mechanism of calcium rise was first suggested by Horn and Marty (1988) to explain the time course of muscarinic receptor-coupled potassium current activation in lacrimal gland cells. Our principal modification of the IP3-accumulation model is the addition of a degradative process for the removal of IP3. Because the dependence of latency on inverse muscarinic receptor occupancy is curved toward the latency axis, this modification is necessary in order to satisfactorily explain the data. A degradative process has previously been assumed in order to explain latency to Ca release evoked by slow photolysis of caged IPs in Xenopus oocytes (Parker and Ivorra, 1992) .
A consequence of this analysis is that we have observed a large cellular variation in IPs degradation rates that is not detectable by biochemical determinations. Indeed, in 28% of the cells we examined, the latency inverse muscarinic receptor occupancy 
i '~'i i
channel increases the open probability of ' nearby IPs-bound channels, allowing regenerative Ca release.
plot appeared linear, indicating very little IP3 degradation. Variability in the concentration of IPs degradation enzymes would confer different abilities to integrate IPs signals in different cells. This is a feature of potential importance in many systems, including dendritic spines (Koch and Zador, 1993) . It could also contribute to the expression of delayed rises in Ca, sites of wave initiation, and stereotyped wave patterns of intercellular Ca waves, all of which have been observed in glial cells (Cornell-Bell, Finkbeiner, Cooper, and Smith, 1990) .
Errors of IP3 Lifetime Estimation from the Latency Analysis
This latency analysis is subject to three types of potential error: (a) latency does not arise entirely from messenger accumulation; (b) the accumulating messenger is not entirely IPs; and (c) the IP3 threshold may be dependent on agonist dose. In addition to accumulation of a second messenger, rate-limiting steps before PLC activation may also contribute to the latent period (for a discussion see Marty, Horn, Tan, and Zimmerberg, 1989) . These steps include binding of agonist-bound receptor to G protein, activation of the G~ subunit, and G~ binding to and activation of PLC. All of these steps take place in < 1 s (Vuong, Chabre, and Stryer, 1984; Berstein, Blank, Jhon, Exton, Rhee, and Ross, 1992) . This matches the observation that the minimum latency to Ca release observed after receptor activation is < 1 s (Horn and Marty, 1988; Neher, Marty, Fukuda, Kubo, and Numa, 1988; . These steps, therefore, would not be able to generate latencies of the length we have observed.
A minimum latency inherent to the transduction machinery (Fuortes and Hodgkin, 1964) would shift the inverse bound receptor concentration, 1/[B], vs latency curve to the right. We subtracted a 0.5-s minimum latency from the examples of Fig. 3 B and found that the fitted IP~ lifetimes decreased very little, from 5.7 s to 5.1 s, and from 13.4 s to 11.2 s.
Saturation of PLC activation would shift the curve upward at high agonist doses, because PLC activation would be lower than predicted from muscarinic receptor occupancy. This would lead to underestimation of the IP~ lifetime. However, N1E-115 cells have "spare receptors" in, at most, 5% of cells (Fisher and Snider, 1987; Wang and Thompson, 1994) , ruling out major distortions by this effect.
Ca feedback might also accelerate the end of the latent period, and if so, this would give latency values that do not depend solely on IP3 formation and degradation. We have not found evidence for Ca feedback in determining latency in N 1E-115 cells, either by augmenting Ca rises with a Ca pump blocker, or by attenuating Ca rises with heavy buffer loads.
The threshold for Ca release could vary with agonist dose if the IP3 receptor desensitizes or inactivates during the latent period, since this would lead to an IP3 threshold that depended on the rate of IP3 increase. Ca-dependent inactivation of the IP3 receptor has been observed to take place in < 1 s (Finch et al., 1991; Iino and Endo, 1992) , but this is too rapid to cause differential effects between a fast and slow rise in IP3. Use-dependent inactivation of IP3 receptors has also been observed, with onset and recovery rates in the range of seconds (Parker and Ivorra, 1990 ). We would not expect to observe this form of IP~ receptor desensitization during the latent period, a time before significant Ca release has begun.
Biochemical Analysis
The biochemical measurement of IP~ degradation gave the same value for the half life for IP3 that was predicted by the latency analysis. This lends support to latency analysis as a means of determining IP3 lifetime in single cells. Both methods were applied to intact cells under physiological conditions. The latency analysis and the biochemical determination could still conceivably give different results for IP3 lifetime, since they are based on observations made at low calcium (latency) and at high or falling calcium (biochemical measurement). The IP3 3-kinase is known to be activated by Ca (Biden and Wollheim, 1986; Takazawa, Lemos, Delvaux, Lejeune, Dumont, and Erneux, 1990) . Because biochemical measurement of IP3 breakdown was made under a condition of cell activation and Ca elevation, the lifetime of IP3 during latency may be longer than our biochemical measurement. Additional determinations of IP~ lifetime in cells with Ca release suppressed will resolve this issue.
The IPs half life of 9 s is within the range of values reported in other preparations. In experiments that separated IP~ from inositol (1,3,4) trisphosphate, Irvine et al. (1985) showed that IP3 produced in response to carbachol was degraded with a half-life of ~ 1 rain. In rat cerebellar microsomes, degradation of IPs occurs more rapidly, with a half life of ~5 s (Stauderman, Harris, and Lovenberg, 1988) . However, the 3-kinase in rat cerebellum is heterogeneously distributed, with high densities of antibody staining occurring in dendritic spines of Purkinje and basket cells (Yamada, Kakita, Mizuguchi, Rhee, Kim, and Ikuta, 1992) , suggesting that the lifetime of IP3 in these structures is shorter than the biochemical determination. In the extreme case of olfactory cells, IP3 levels have been observed to rise and fall in 0.1 s or less (Breer et al., 1990) .
The variation in lifetime among these cell types may reflect different signaling roles for IP~. The endocrine function of parotid glands is modulated over minutes, whereas sensory neurons respond to odorants in a fraction of a second. Likewise, a short lifetime of IP3 would also put spatial and temporal limits on the extent of IP~ signaling in an extended structure such as a dendritic arbor.
The rise in total IP~ concentration from 10 nM to 35 nM is consistent with known information on IPs receptor properties. N 1 E-115 cells express Type 3 IP3 receptors ~J. S. Coggan, I. K. Kovacs, and S. H. Thompson, unpublished results), which have a measured affinity for IP3 of 29 (Yamamoto-Hino, Sugiyama, Hikichi, Mattei, Hasegawa, Sekine, Sakurada, Miyawaki, Furuichi, Hasegawa, and Mikoshiba, 1994) to 151 nM (Maranto, 1994) . This is consistent with the idea that stimulation of muscarinic receptors leads to a significant increase in the number of bound IP~ receptors.
Implications for Calcium Oscillations and Waves
Information on the lifetime of IP3 is necessary for experimental analysis and quantitative modeling of Ca oscillations. In models of Ca oscillation the lifetime of IP~ is assumed or inferred from measurements from whole tissue Keizer and De Young, 1992) . Our work in N1E-115 cells shows that this parameter can vary over a fivefold range among individual cells even in a clonal cell line.
The relatively long lifetime of IPs imposes a requirement that a successful model of Ca release must allow Ca oscillations to occur with, at most, small peak-to-peak changes in IP3. We observe agonist-evoked calcium oscillations in N 1 E-115 cells with periods as fast as 3 s (Wang and Thompson, unpublished observations) . Assuming = 10 s, in a fast Ca oscillator no more than 14% of IP3 that was present at the peak of the oscillation would be destroyed by the time of the trough. This is an upper limit to the peak-to-peak variation, because it does not consider the additional contribution of continued IP~ generation. This implies that IP3 oscillation may not be necessary for generating Ca spikes, and indeed, a constant level of IP~ receptor stimulation causes Ca oscillations (Wakui, Potter, and Petersen, 1989; Lechleiter and Clapham, 1992; DeLisle and Welsh, 1992) . However, if the variations in IP3 straddle a region of the dose-response activation curve of the IP3 receptor that is steep because of positive cooperativity, then a small-amplitude IPs oscillation might still have functional significance in making a calcium oscillation.
Our experiments show that unlike response latency, the rise time of the Ca signal has a strong Ca feedback component. This is supported by the observation that on a very short time scale, Ca acts locally and positively to cause more Ca release from IP3-sensitive stores (Finch et al., 1991; Iino and Endo, 1992) . Further exploration of this possibility requires the study of events that depend on local feedback. One model for such a study would be the propagation of Ca waves across cells.
APPENDIX A
IP3 Accumulation Model of Latency
We modeled the accumulation of IP~ in cytoplasm as a process in which IP~ is generated by activated PLC (PLC*) in a muscarinic receptor occupancy-dependent manner. The steps leading to IP~ formation are the association of carbachol with muscarinic receptors, activation of ~-subunits of the G protein by agonist-receptor complex, and association of G~ with PLC to form PLC*. All of these steps are rapid. Receptors can associate with and activate G proteins in milliseconds (Vuong et al., 1984) . Furthermore, PLC[31 has been demonstrated to act as a GTPase activating protein (Berstein et al., 1992) , so that once activated, PLC molecules are inactivated in < 1 s. This means that in response to a step rise in agonist, [PLC*]jumps to a new equilibrium in 1 s or less (Fig. 9 A) . Feedback by the other branch of the signaling pathway, via protein kinase C, does not occur in N 1E-115 cells (Wang, Mathes, and Thompson, 1993) . If there are no saturating steps in this activation sequence then [PLC*] is proportional to the rate at which it is activated, and therefore proportional to the amount of bound receptor. Saturation in the signaling cascade would appear as a leftward shift in the dose-response curve relative to the receptor binding curve. This does not occur for muscarinic M 1 receptors in N 1 E-115 cells, because the binding KD for carbachol is 100 ---5 p,M (McKinney and Richelson, 1986) and the carbachol concentration needed for half-maximal activation of Ca release is 96 -+ 8 ~M (Wang and Thompson, manuscript in preparation) .
When IP~ degradation is considered, the kinetics of IP~ in a cell are governed by the equation . The principal degradative enzyme, the 3-kinase, has Km = 0.6-1.5 I~M (Irvine, Letcher, Heslop, and Berridge, 1986; Biden and Wollheim, 1986) . The affinity of IP3 for its neuronal receptor is in the nanomolar range (Furuichi, Yoshikawa, Miyawaki, Wada, Maeda, and Mikoshiba, 1989; Yamamoto-Hino et al., 1994; Maranto, 1994) , and our measurements likewise give low nanomolar concentrations of IP3 after agonist presentation. At these concentrations the degradative enzyme is not saturated, and so k2 is approximately constant during the latent period when IP3 receptors are not yet activated. For the initial condition lIP3] = 0 at t = 0, the solution of Eq. 1 is [IP~] = [B] kl/k2 (1 -e-k2t). Because the dose-response curve of IP~ action upon its receptor to induce Ca release is steep (Meyer, Holowka, and Stryer, 1988; Parker and Ivorra, 1992) , Ca release will increase sharply as IP3 builds up to a threshold Ithr (Fig. 9A and B 
showing that a plot of 1/[B] vs L (Fig. 9 C) will take the form of a single exponential with time constant "r = 1/k2, where ~ is the single-cell lifetime of IP3. A fit of this plot to a single exponential will therefore give a measure of the rate at which a single cell degrades IP~. The initial condition [IPs] = 0 was chosen for simplicity of presentation, but the interpretation is the same if some nonzero resting level of IPs is assumed. We measured latencies in single cells for a range of agonist doses and fitted these data to Eq. 3 to obtain ~, using a Marquardt nonlinear curve fitting algorithm (Bevington, 1969) . We used KD = 100 I~M to compute I/[B], assuming single-site binding to the M 1 receptor. This analysis is a biochemical enzyme assay performed on single cells, with inverse latency as the measure of IP3 production. In the case of no IP~ degradation (k2 = 0) the relation between inverse muscarinic receptor occupancy and latency is linear and is equivalent to a Lineweaver-Burk double-reciprocal plot, with KD corresponding to Km and L corresponding to 1/V. A model of IP3 production without degradation has been used to model delays in receptor-evoked responses (Neher et al., 1988; Marty, Horn, Tan, and Zimmerberg, 1989) .
The Expected Time Course of 1P3 in Cell Populations
If the degradation of IP~ follows first-order kinetics, then after a pulse of carbachol, the IP~ level in single cells will drop exponentially as 10e -kt, where I0 is the IP3 concentration at the end of the carbachol pulse. If the rate constants are exponentially distributed in the population with mean rate constant (k), the average time course of IP3 can be calculated by integrating the single-cell time courses over the population, assuming I0 is independent of k:
[IPs] = f (single-cell time course)(probability distribution of rate constants) dk We thank the staff of the Hopkins Marine Station for excellent support through the course of this work, and M. K. Meffert for advice on IP3 determinations.
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